Our Anomatic Pharma team will be attending the international conference sponsored by the Inhalation Drug Delivery Association next week in Shen Yang ,China in July 4-6. We will be showcasing our capabilities for MDI canisters and SMI cartridges, reach out to schedule time with our team to help with your new or existing MDI and SMI projects! We look forward to seeing you next week! #SMI; #MDI; #IDDA ; #Anomaticpharma #Drugdeliverydevices
Anomatic Corporation’s Post
More Relevant Posts
-
Discover the future of medicine with pharmacosomes in the 57th issue of the IPA-CPD E-times, written by Dr. Suwarna Bobde .These innovative carriers are revolutionizing drug delivery for enhanced effectiveness. Unlock the secrets to better health in our latest issue! To read the complete magazine, check out: https://rb.gy/s4pnh8 || Indian Pharmaceutical Association || Manjiri Gharat || Raj Vaidya || #IPA #IPACPD #CPD_Etimes #pharmacosomes #ndds
To view or add a comment, sign in
-
Engagement Manager at Nomura Consulting | LBS MBA | IIT Bombay | Lifesciences | Indo-Japan | Japanese Bilingual | Venture Capital
💊 The GLP1-RA space is heating up in India 🎖 Market leaders are going to launch Ozempic and Mounjaro reportedly next year as patent expiry for semaglutide looms by 2026 (as reported here) but more branded (Sun Pharma) and generic versions (Cipla, Dr Reddy, Biocon) are in the pipeline https://lnkd.in/gWABtW5w 🔴 In Jan this year we had the launch of first GLP1 (Liraglutide) biosimilar - Lirafit by Glenmark Pharmaceuticals (prefilled injector pen ) which is priced at Rs 1500/month drastically reducing cost by 70% With a market this hot timing is all that matters! Source: https://lnkd.in/gHQppSVd
To view or add a comment, sign in
-
Read about the future of transdermal delivery with Transferosomes in the 58th issue of the IPA-CPD E-times, written by Suwarna Bobde . Discover how these ultra-deformable carriers are revolutionizing drug administration through the skin. Read more: https:/bit.ly/58thetimes Indian Pharmaceutical Association || Manjiri Gharat || Raj Vaidya #IPA #IPA_CPD #58thEtimes #NDDS #Transferosomes #TransdermalDelivery #PharmaceuticalInnovation #NextGenMedicine"
To view or add a comment, sign in
-
From biosimilars to generics: Navigate the complex world of drug costs with the 8th annual Navitus Drug Trend Report. Download now: https://ow.ly/IIp050SXMT8 #PharmacyCosts
To view or add a comment, sign in
-
🚀Exciting Market News Unveiled! Dive into Oman's pharmaceutical landscape transformation... 🌐Discover the future pricing dynamics and the anticipated tweaks to the International Reference Pricing (IRP) basket. Whilst Oman has previously used International Reference Pricing (IRP) for setting drug prices, new changes in the IRP basket are expected. 📆 Mark your calendars for July 1, 2024 – when the evolution begins! 🌍💊 #RevolutionizingHealthcare #OmanPharmaRevamp #PricingInnovation #GlobalHealthInsights
To view or add a comment, sign in
-
Unlock the Key to Heart Health with the BNP Test. Discover about this powerful marker for detecting heart failure early, in the Laboratory Information feature of the 58th IPA-CPD E-times, written by Dr. Satyavardhan Rao Nittu, PharmD. Your heart deserves the best care! Read more: https:/bit.ly/58thetimes Indian Pharmaceutical Association || Manjiri Gharat || Raj Vaidya || #IPA #IPA_CPD #58thEtimes #BNPtest
To view or add a comment, sign in
-
𝐒𝐭𝐫𝐢𝐝𝐞𝐬 𝐏𝐡𝐚𝐫𝐦𝐚 𝐠𝐞𝐭𝐬 𝐔𝐒𝐅𝐃𝐀 𝐧𝐨𝐝 𝐟𝐨𝐫 𝐏𝐫𝐞𝐠𝐚𝐛𝐚𝐥𝐢𝐧 𝐂𝐚𝐩𝐬𝐮𝐥𝐞 📌 Strides pharma received permission from the United States Food and Drug Administration (USFDA) to sell a generic medicine for nerve pain. 📌Strides Pharma Global Pte Limited, a subsidiary of the business, has acquired approval from the US drug agency for Pregabalin capsules in various strengths (25 mg, 50 mg, 75 mg, 150 mg, 100 mg, 200 mg, 225 mg, and 300 mg). 📌The product is bioequivalent and therapeutically equivalent to Upjohn US's Lyrica pills, which are a Reference Listed Drug. The capsule is used to treat fibromyalgia. #stridespharma #usfda #anda #pregabalin
To view or add a comment, sign in
-
Canada's move towards pharmacare aims to enhance drug coverage for Canadians. As reported by Generics Bulletin's Adam Zamecnik, while the Canadian Generic Pharmaceutical Association and Biosimilars Canada support better access to prescription drugs for Canadians, there are reservations, including the potential impacts on the supply of generic and biosimilar medicines. Check out the article below to learn more. https://lnkd.in/eCTFbKDP
To view or add a comment, sign in
-
Remi Turbet Delof from Systech has been invited by the Algerian Ministry of Pharmaceutical Affairs to share the floor with them on July 4th, for the pharma industry. He'll be sharing his insights on the significance of track & trace in the #pharma supply chain, highlighting #serialization & #aggregation, anti-counterfeiting benefits, and global trends🌍 at ANPHA - Association Nationale des Pharmaciens Algériens in Alger. To know more about track and trace solutions at Systech please refer to https://bit.ly/3XUHrSF #ANPHA #supplychainvisibility #anticounterfeit #trackandtrace
To view or add a comment, sign in
-
This is a story of success 2014 - Validation of the Olon #Daptomycin process 2017 - Launch of Olon Daptomycin in the US market, first API supplier to launch generic Daptomycin 2018 - Launch of Olon Daptomycin in Europe, first API supplier to launch generic Daptomycin 2024 - Olon makes investments towards significant expansion, reaching double its production capacity We celebrate 10 years of #Olon Daptomycin, announcing doubled production capacity #pharmasupplychain #pharma
To view or add a comment, sign in
6,582 followers